Bridging together the Middle-Income Trap (MIT) literature with the Global Value Chains (GVCs) approach may provide a more fine-grained understanding of the middle-income (MI) countries' developmental dilemmas. While the former identifies the structural challenges these countries face, the latter...

The bioeconomy is a growing sector in both high- and low-income countries, closely linked to innovation. However, knowledge creation and innovation flows remain underexplored due to their complexity. This study aims to introduce the Knowledge and Innovation System for the Bioeconomy (KISB) to...

Purpose The purpose of this study is to identify papers that have produced the most significant impact on research on strategic alliances in the biotechnology industry. The authors attempt to illustrate the thematic evolution of its intellectual structure through 616 papers published between...

Europe is building its bioeconomy using renewable biological resources, such as microorganisms, crops and forests, to produce food supplies, industrial materials and energy resources. The resulting new green value chains and cost-effective industrial processes will help boost the wider economy...

Europe is building its bioeconomy using renewable biological resources, such as microorganisms, crops and forests, to produce food supplies, industrial materials and energy resources. The resulting new green value chains and cost-effective industrial processes will help boost the wider economy...

This briefing identifies bio-based innovations with high potential to support the forthcoming updated EU bioeconomy strategy. The briefing also relates to broader EU climate and biodiversity goals, helping inform national and regional strategies. The analysis draws on data from EU and...

AI techniques are helping researchers to make valuable new discoveries across disciplines such as biology, neuroscience and biotechnology. Through the analysis of vast datasets and the identification of complex patterns, AI is speeding up the discovery of new therapeutic drugs and helping us to...

AI techniques are helping researchers to make valuable new discoveries across disciplines such as biology, neuroscience and biotechnology. Through the analysis of vast datasets and the identification of complex patterns, AI is speeding up the discovery of new therapeutic drugs and helping us to...

Today, the EU is at the heart of scientific research and innovation in new, bio-based manufacturing solutions that will bolster the industrial competitiveness and sustainability of our economies. Biotechnology has the potential to improve our quality of life through a range of breakthrough...

This report presents a patent landscape analysis investigating the innovation trends within the industrial biotechnology (IB) sector from 2015 to 2020. The study's primary objective is to identify the geographical hotspots of innovation, the key players, and the role of different types of...

DNA carries the genetic instructions that dictate how organisms develop and function - acting as a blueprint for life. By digging deeper into genetic differences and harnessing the power of gene editing, EU-funded researchers are opening up new possibilities in the medical and biotech fields....

Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and...

This paper examines the effects of data privacy regulation on R&D investment in the pharmaceutical and biotechnology sectors. In these industries, access to personal health data is essential for innovation, particularly in clinical research. Leveraging a firm-level panel of the world's top R&D...

Great efforts in biotechnology are being made to reduce the use of fossil fuels and to drive a transition toward a bioeconomy. However, these early-stage technical concepts also carry sustainability risks at ecological, social and economic levels due to large-scale biomass flows when scaled to...

We evaluate potential adoption of drought tolerant HB4 technology in soybeans. Empirical analysis focuses on Argentine agriculture. The following two-step approach is used. First, a choice experiment is carried out to estimate average willingness-to-pay (WTP) for the HB4 technology. Average WTP...

This Communication aims to unlock the full benefits of biotechnologies and biomanufacturing, which are crucial for the competitiveness and modernisation of EU industry and offer high growth and productivity potential.

The innovation in the bioeconomy sectors is a key enabler for transitioning towards a carbon-neutral economy and complying with the objectives of the EU's Bioeconomy Strategy. Consequently, the EU-Bioeconomy Monitoring System places significant emphasis on indicators of research and innovation...

The European Union (EU) is at an important point for developing its industrial biotechnology (IB) sector, as emerging biotechnologies advances merge with traditional industry. This external expert report reviews the EU's IB sector and associated emerging technologies, looking at its strengths,...

The study explores entrepreneurial ecosystems, which emphasize the impact of regional context on entrepreneurship, with a particular focus on the health sector. Given its innovation and knowledge intensity, coupled with industry-specific challenges, the health sector serves as an ideal case for...

A sustainable ocean economy, or blue economy, encompasses economic activities utilizing marine resources while prioritizing the long-term health of oceans. While its potential to contribute to Gross Domestic Product (GDP) is acknowledged, limited research explores its specific influence on...

This study explored the factors influencing cooperative innovation in environmentally friendly agricultural biotechnology in China. First, we constructed an evolutionary game model comprising the factors of net income of cooperative innovation, net income of independent innovation, market...

The oil industry is responsible for production of many products in common use, such as plastic and fuel, which are used in various activities in modern society. However, the exploitation of these hydrocarbons has been considered aggressive to the environment and their reservoirs are not...

Myriad Genetics is one of the leading biotechnology firms with a specialization in genetic testing, cancer research and precision medicine. Myriad has filed its first patent application in 1995 and now developed a patent portfolio of more than a thousand patent applications. It is almost 10...

Biotechnology has never demonstrated its benefits to society more than in 2021. The SARS-CoV-2 virus that caused the CoVID-19 pandemic met a formidable opponent in mRNA vaccines developed and supplied by Moderna and Pfizer/BioNTech. These vaccines are claimed in myriad – not Myriad – patents...

Climate change has induced an ecological crisis necessitating reconsideration of how the law should manage human interactions with ecological systems. In most Western legal regimes, conservation policy has principally sought to advance historical or natural preservation or sustained yield...

Through a longitudinal study of the product development portfolios of 457 US-based firms in the biotechnology industry, we investigate how prolific inventors shape a firm’s innovative direction following product development failure. Contrary to received wisdom, we argue and demonstrate that an...